{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:22:07Z","timestamp":1790878927119,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T00:00:00Z","timestamp":1455062400000},"content-version":"vor","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.jacc.2014.12.010","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T16:12:06Z","timestamp":1422893526000},"page":"480-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":143,"title":["Hyponatremia in Acute Decompensated Heart Failure"],"prefix":"10.1016","volume":"65","author":[{"given":"Frederik H.","family":"Verbrugge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Steels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Grieten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Nijst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H. Wilson","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Mullens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2014.12.010_bib1","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.amjmed.2013.07.021","article-title":"Prevalence of hyponatremia and association with mortality: results from NHANES","volume":"126","author":"Mohan","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2014.12.010_bib2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archinternmed.2009.513","article-title":"Impact of hospital-associated hyponatremia on selected outcomes","volume":"170","author":"Wald","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2014.12.010_bib3","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/eurheartj\/ehl542","article-title":"Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry","volume":"28","author":"Gheorghiade","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.12.010_bib4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.cardfail.2012.06.415","article-title":"Progression of hyponatremia is associated with increased cardiac mortality in patients hospitalized for acute decompensated heart failure","volume":"18","author":"Konishi","year":"2012","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2014.12.010_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/CIRCHEARTFAILURE.112.000106","article-title":"Outcome differences in community- versus hospital-acquired hyponatremia in patients with a diagnosis of heart failure","volume":"6","author":"Shchekochikhin","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2014.12.010_bib6","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM200005253422107","article-title":"Hyponatremia","volume":"342","author":"Adrogue","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.12.010_bib7","doi-asserted-by":"crossref","first-page":"2B","DOI":"10.1016\/j.amjcard.2005.03.002","article-title":"Hyponatremia in congestive heart failure","volume":"95","author":"Oren","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/364341a0","article-title":"Mechanosensitive channels transduce osmosensitivity in supraoptic neurons","volume":"364","author":"Oliet","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2014.12.010_bib9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0008-6363(01)00328-5","article-title":"Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects","volume":"51","author":"Bankir","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2014.12.010_bib10","first-page":"F3","article-title":"Molecular physiology of urinary concentrating mechanism: regulation of aquaporin water channels by vasopressin","volume":"272","author":"Knepper","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib11","first-page":"R53","article-title":"Antidiuretic effect of subnormal levels of arginine vasopressin in normal humans","volume":"259 1 Pt 2","author":"Andersen","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib12","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1172\/JCI113534","article-title":"Calcium and cyclic adenosine monophosphate as second messengers for vasopressin in the rat inner medullary collecting duct","volume":"81","author":"Star","year":"1988","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2014.12.010_bib13","first-page":"R243","article-title":"Localization of the vasopressin V1a and V2 receptors within the renal cortical and medullary circulation","volume":"273 1 Pt 2","author":"Park","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev.ph.56.030194.003431","article-title":"Hormonal signaling and regulation of salt and water transport in the collecting duct","volume":"56","author":"Breyer","year":"1994","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0002-9149(86)90065-2","article-title":"Arginine vasopressin and the renal response to water loading in congestive heart failure","volume":"58","author":"Goldsmith","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM198107303050506","article-title":"Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure","volume":"305","author":"Szatalowicz","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2014.12.010_bib17","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0735-1097(83)80040-0","article-title":"Increased plasma arginine vasopressin levels in patients with congestive heart failure","volume":"1","author":"Goldsmith","year":"1983","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib18","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","article-title":"Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)","volume":"82","author":"Francis","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.12.010_bib19","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1172\/JCI119312","article-title":"Upregulation of aquaporin-2 water channel expression in chronic heart failure rat","volume":"99","author":"Xu","year":"1997","journal-title":"J\u00a0Clin Investigation"},{"key":"10.1016\/j.jacc.2014.12.010_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9343(82)90825-7","article-title":"Neurogenic disorders of osmoregulation","volume":"72","author":"Robertson","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2014.12.010_bib21","first-page":"H396","article-title":"Plasma vasopressin response to osmotic and hemodynamic stimuli in heart failure","volume":"248 3 Pt 2","author":"Uretsky","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib22","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1172\/JCI107521","article-title":"The role of blood osmolality and volume in regulating vasopressin secretion in the rat","volume":"52","author":"Dunn","year":"1973","journal-title":"Journal Clin Invest"},{"key":"10.1016\/j.jacc.2014.12.010_bib23","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0735-1097(86)80333-3","article-title":"Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system","volume":"7","author":"Creager","year":"1986","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib24","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0002-9343(82)90823-3","article-title":"Disorders of urinary concentration and dilution","volume":"72","author":"Jamison","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2014.12.010_bib25","first-page":"11","article-title":"Micropuncture studies of tubular function in the mammalian kidney","volume":"5","author":"Gottschalk","year":"1962","journal-title":"Folia Med Neerl"},{"key":"10.1016\/j.jacc.2014.12.010_bib26","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI40145","article-title":"The\u00a0Na+-dependent chloride-bicarbonate exchanger\u00a0SLC4A8 mediates an electroneutral Na+\u00a0reabsorption process in the renal cortical collecting ducts of mice","volume":"120","author":"Leviel","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2014.12.010_bib27","doi-asserted-by":"crossref","first-page":"F923","DOI":"10.1152\/ajprenal.00192.2006","article-title":"Regulation of cation transport in the distal nephron by mechanical forces","volume":"291","author":"Satlin","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/hrt.32.3.399","article-title":"Assessment of proximal tubular sodium reabsorption during water diuresis in patients with heart disease","volume":"32","author":"Gibson","year":"1970","journal-title":"Br Heart J"},{"key":"10.1016\/j.jacc.2014.12.010_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ejhf.35","article-title":"The kidney in congestive heart failure: 'are natriuresis, sodium, and diuretics really the good, the bad and the ugly?'","volume":"16","author":"Verbrugge","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2014.12.010_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0002-9343(64)90161-5","article-title":"An explanation for abnormal water retention and hypoosmolality in congestive heart failure","volume":"36","author":"Bell","year":"1964","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2014.12.010_bib31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1172\/JCI104035","article-title":"An explanation for and experimental correction of the abnormal water diuresis in cirrhosis","volume":"39","author":"Schedl","year":"1960","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2014.12.010_bib32","first-page":"F321","article-title":"Osmotic and nonosmotic control of vasopressin release","volume":"236","author":"Schrier","year":"1979","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM199908193410806","article-title":"Hormones and hemodynamics in heart failure","volume":"341","author":"Schrier","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.12.010_bib34","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.jacc.2011.07.042","article-title":"Impaired natriuretic and renal endocrine response to acute volume expansion in pre-clinical systolic and diastolic dysfunction","volume":"58","author":"McKie","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib35","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2010.04.004","article-title":"HFSA 2010 comprehensive heart failure practice guideline","volume":"16","author":"Lindenfeld","year":"2010","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2014.12.010_bib36","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2014.12.010_bib37","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1042\/CS20070193","article-title":"Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?","volume":"114","author":"Paterna","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jacc.2014.12.010_bib39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.amjcard.2008.08.043","article-title":"Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure","volume":"103","author":"Paterna","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib40","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.cardfail.2009.06.002","article-title":"Long-term effects of dietary sodium intake on cytokines and neurohormonal activation in patients with recently compensated congestive heart failure","volume":"15","author":"Parrinello","year":"2009","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2014.12.010_bib41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10741-005-6127-6","article-title":"Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry","volume":"9","author":"Fonarow","year":"2004","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2014.12.010_bib42","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1152\/ajplegacy.1961.200.6.1139","article-title":"Micropuncture study of net transtubular movement of\u00a0water and urea in nondiuretic mammalian kidney","volume":"200","author":"Lassiter","year":"1961","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib43","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1152\/ajplegacy.1963.204.4.532","article-title":"Micropuncture study of composition of loop of\u00a0Henle fluid in desert rodents","volume":"204","author":"Gottschalk","year":"1963","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1751-7133.2008.00037.x","article-title":"Loop diuretics can cause clinical natriuretic failure: a prescription for volume expansion","volume":"15","author":"Ali","year":"2009","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.jacc.2014.12.010_bib45","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.12.010_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.12.010_bib47","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","article-title":"Combination of loop diuretics with thiazide-type diuretics in heart failure","volume":"56","author":"Jentzer","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0735-1097(02)02694-3","article-title":"Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines","volume":"41","author":"Bozkurt","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib49","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejim.2011.04.008","article-title":"Appropriateness and complications of the use of spironolactone in patients treated in a heart failure clinic","volume":"22","author":"Goland","year":"2011","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jacc.2014.12.010_bib50","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/01.CIR.100.12.1311","article-title":"Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction","volume":"100","author":"Cooper","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.12.010_bib51","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI102665","article-title":"The extrarenal correction of alkalosis associated with potassium deficiency","volume":"31","author":"Cooke","year":"1952","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2014.12.010_bib52","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0140-6736(81)92034-1","article-title":"Effects of magnesium infusions in diuretic induced hyponatraemia","volume":"1","author":"Dyckner","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2014.12.010_bib53","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00007611-199302000-00027","article-title":"Pseudohyponatremia in multiple myeloma","volume":"86","author":"Vaswani","year":"1993","journal-title":"South Med J"},{"key":"10.1016\/j.jacc.2014.12.010_bib54","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1056\/NEJM199808273390914","article-title":"Intravenous immune globulin and pseudohyponatremia","volume":"339","author":"Lawn","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.12.010_bib55","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ki.2008.335","article-title":"Milky plasma, diabetes, and severe hyponatremia","volume":"75","author":"Lai","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2014.12.010_bib56","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0002-9343(99)00055-8","article-title":"Hyponatremia: evaluating the correction factor for hyperglycemia","volume":"106","author":"Hillier","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2014.12.010_bib57","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1053\/j.ajkd.2003.10.028","article-title":"Contrast-induced translocational hyponatremia and hyperkalemia in advanced kidney disease","volume":"43","author":"Sirken","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2014.12.010_bib58","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejheart.2008.01.008","article-title":"Hyponatraemia in acute heart failure is a marker of increased mortality but not when associated with hyperglycaemia","volume":"10","author":"Milo-Cotter","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2014.12.010_bib59","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s00134-014-3210-2","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia","volume":"40","author":"Spasovski","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jacc.2014.12.010_bib60","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4065\/76.5.559","article-title":"Central pontine myelinolysis","volume":"76","author":"Pirzada","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2014.12.010_bib61","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1445-5994.2012.02805.x","article-title":"Hazards of potassium and multiple sources of sodium in causing osmotic demyelination","volume":"42","author":"Kingston","year":"2012","journal-title":"Intern Med J"},{"key":"10.1016\/j.jacc.2014.12.010_bib62","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM200005183422006","article-title":"Hypernatremia","volume":"342","author":"Adrogue","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2014.12.010_bib63","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCHEARTFAILURE.111.961011","article-title":"Impact of change in serum sodium concentration on mortality in patients hospitalized with heart failure and hyponatremia","volume":"4","author":"Madan","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2014.12.010_bib64","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1136\/heartjnl-2012-302334","article-title":"Improvement of hyponatraemia during hospitalisation for acute heart failure is not associated with improvement of prognosis: an analysis from the Korean Heart Failure (KorHF) registry","volume":"98","author":"Lee","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2014.12.010_bib65","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1388-9842(00)00094-5","article-title":"Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure","volume":"2","author":"Paterna","year":"2000","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2014.12.010_bib66","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1067\/mhj.2003.166","article-title":"Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects","volume":"145","author":"Licata","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2014.12.010_bib67","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cardfail.2010.11.003","article-title":"Changes in estimating echocardiography pulmonary capillary wedge pressure after hypersaline plus furosemide versus furosemide alone in decompensated heart failure","volume":"17","author":"Parrinello","year":"2011","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2014.12.010_bib68","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MAJ.0b013e31820f10ad","article-title":"Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study)","volume":"342","author":"Paterna","year":"2011","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jacc.2014.12.010_bib69","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijcard.2011.11.087","article-title":"Hypertonic saline solution for prevention of renal dysfunction in patients with decompensated heart failure","volume":"167","author":"Issa","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib70","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.cardfail.2014.01.012","article-title":"Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure","volume":"20","author":"Okuhara","year":"2014","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2014.12.010_bib71","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jacc.2005.01.059","article-title":"Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study","volume":"45","author":"Paterna","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib72","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.numecd.2009.10.014","article-title":"Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading","volume":"21","author":"Tuttolomondo","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2014.12.010_bib73","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/CIRCULATIONAHA.108.765289","article-title":"Arginine vasopressin antagonists for the treatment of heart failure and hyponatremia","volume":"118","author":"Finley","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.12.010_bib74","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/157489008784705403","article-title":"Conivaptan: potential therapeutic implications in heart failure","volume":"3","author":"Chen","year":"2008","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"10.1016\/j.jacc.2014.12.010_bib75","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/eurjhf\/hfq226","article-title":"Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study","volume":"13","author":"Aronson","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2014.12.010_bib76","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cardfail.2013.04.001","article-title":"Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan","volume":"19","author":"Hauptman","year":"2013","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2014.12.010_bib77","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.0000070422.41439.04","article-title":"Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial","volume":"107","author":"Gheorghiade","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.12.010_bib78","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","article-title":"Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial","volume":"291","author":"Gheorghiade","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2014.12.010_bib79","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1210\/jc.2005-2287","article-title":"Efficacy and safety of oral conivaptan: a V1A\/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia","volume":"91","author":"Ghali","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2014.12.010_bib80","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000106456","article-title":"Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia","volume":"27","author":"Zeltser","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jacc.2014.12.010_bib81","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2014.12.010_bib82","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/eurjhf\/hfs174","article-title":"Thirst in heart failure: a systematic literature review","volume":"15","author":"Waldreus","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2014.12.010_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cardfail.2012.11.007","article-title":"A\u00a0randomized controlled pilot study of outcomes of strict allowance of fluid therapy in hyponatremic heart failure (SALT-HF)","volume":"19","author":"Albert","year":"2013","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2014.12.010_bib84","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/0003-4819-100-6-777","article-title":"Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia","volume":"100","author":"Dzau","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2014.12.010_bib85","doi-asserted-by":"crossref","first-page":"782","DOI":"10.7326\/0003-4819-100-6-782","article-title":"Correction of dilutional hyponatremia in severe chronic heart failure by converting-enzyme inhibition","volume":"100","author":"Packer","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2014.12.010_bib86","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure","volume":"325","author":"Packer","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.12.010_bib87","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0002-8703(99)70250-4","article-title":"Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)","volume":"138","author":"O'Connor","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2014.12.010_bib88","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2008.02.083","article-title":"Sodium nitroprusside for advanced low-output heart failure","volume":"52","author":"Mullens","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib89","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.amjcard.2008.12.028","article-title":"Usefulness of Isosorbide Dinitrate and Hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure","volume":"103","author":"Mullens","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib90","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jacc.2012.11.005","article-title":"Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes","volume":"61","author":"Metra","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.12.010_bib91","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/eurheartj\/eht459","article-title":"A\u00a0randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure","volume":"35","author":"Ponikowski","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.12.010_bib92","unstructured":"ClinicalTrials.gov. Effect of serelaxin versus standard of care in acute heart failure (AHF) patients (RELAX-AHF-EU). February 14, 2014. Updated August 26, 2014. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT02064868. Accessed December 2,\u00a02014."}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510971407394X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510971407394X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:10:39Z","timestamp":1760015439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510971407394X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S073510971407394X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2014.12.010","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyponatremia in Acute Decompensated Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2014.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}